RT-PCR Kit Recalled Due to False Positive Test Results
Qiagen's FGFR RGQ RT-PCR Kit may produce false positive results, leading to incorrect lab reports. This could expose cancer patients to inappropriate or suboptimal treatment.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with increased false positive test results that could lead to inappropriate cancer treatment. No illnesses or injuries have been reported; the harm is potential only.
Plain-English summary
Qiagen Sciences LLC is recalling its FGFR RGQ RT-PCR Kit (reference 8747010), a diagnostic kit used to test for specific genetic markers. The recall affects 9 kits that were distributed to healthcare facilities in Indiana, North Carolina, Minnesota, Texas, and to international locations including Belgium, China, Germany, Jordan, Italy, Netherlands, Malaysia, Spain, and Thailand. The affected lots are 169047135 (expiration 12.06.2022) and 172017806 (expiration 10.11.2022).
These kits have an increased rate of false positive results, meaning the test may incorrectly indicate the presence of a genetic marker when it is not actually present. False positive results could be reported by laboratories without correction, leading physicians and patients to act on inaccurate diagnostic information.
This kit is used to guide cancer treatment decisions. A false positive result could cause patients to receive inappropriate or suboptimal anti-cancer treatment and to experience unnecessary side effects from medications that would not otherwise be needed. Patients and healthcare providers should contact Qiagen Sciences LLC regarding any tests performed with these kits, and laboratories should review results from affected lots for accuracy.
The recalled product
- Product
- FGFR RGQ RT-PCR Kit (RUO, not IVD) REF 8747010
- Manufacturer
- Qiagen Sciences LLC
- Affected units
- 9
Distribution
Part of a larger recall action
This product is one of 3 recalled by Qiagen Sciences LLC under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Qiagen Sciences LLC
See all →- HighRespiratory Diagnostic Cartridges Recalled for Risk of False Test Results
FDA (Devices) · 2025-04-09
- HighQiagen QIAcube Connect MDx heating failure may cause erroneous diagnostic results
FDA (Devices) · 2024-07-24
- HighNucleic Acid Isolation Device Recall: EZ2 Connect MDx-IVD Heater Failure
FDA (Devices) · 2024-04-17
- HighQIAstat-Dx Respiratory SARS-CoV-2 Test Kit Recalled for False Result Risk
FDA (Devices) · 2023-06-14
- HighLaboratory device displays incorrect sample volume guidance during setup
FDA (Devices) · 2022-09-21
Same hazard · false positive
See all →- HighHealthmark ProChek-II Medical Tests Recalled for Expired Ingredient
FDA (Devices) · 2026-09-02
- HighAmyloid 1-42-N plasma calibrators recalled over falsely elevated results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma cartridges recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma calibrators recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighAmyloid plasma controls recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11